PSM Guest Speakers
Name | Affiliation |
Andrea Edling PhD | Associate Director, Global Research Program and Portfolio Management, Sanofi US |
Alison McVie-Wylie PhD | Head of Biologics Pharmacology and Pharmacokinetics Rare Disease Research, Sanofi R&D |
Justine Rovedo | Sr. Director, Global Operations Portfolio Management, Alexion Pharmaceuticals |
Gloria Lau | Sr Director, Program management, Alnylam Pharmaceuticals |
Timothy Weeden | Senior scientist, Biologics Research, Sanofi R&D |
Sherry Cao PhD | Director Immunology Systems Computational Biology, Abbvie Inc. |
Yana Stackpole | Glucore Inc., Boston |
Maureen Magnay PhD | Principal scientist, Biologics Research, Sanofi R&D |
Andrew Good DPhil | Scientific fellow, Schrodinger, Inc., Cambridge, |
Renato Skerlj PhD | VP of Drug Discovery and Preclinical Development, Lysosomal Therapeutics, Cambridge |
Tony Ip PhD | Professor, Molecular Medicine, University of Massachusetts Medical School |
Steven Theroux | Professor of Biology, assumption College, Worcester |
Samuel S. Chuang PhD | Scientific Advisory Services, Charles River |
Michael Naill PhD | Director Manufacturing Sciences, Bluebird Bio, Cambridge |
Liz Proos | Director of Formulation Development, Microchips Biotech, Lexington |
Abraham Scaria PhD | VP & Head of Ophthalmology, Casebia Therapeutics, Cambridge |
Richard Steel | Medical Intelligence and Patient Perspective, Sanofi, Framingham |
Ajeeta Dash PhD | Medical Intelligence and Patient Perspective, Takeda Pharmaceuticals Inc., Cambridge |
Tom McMurray PhD | Director, Business Development, Boston University Office of Technology Development |
John Tagliomonte | Entrepreneur-in-Residence, MAssBIO, Cambridge |